Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PPP5C antisense RNA 1 (PPP5C-AS1) is presumed to be an antisense long non-coding RNA transcribed from the PPP5C genomic region but presently lacks characterization, functional annotation, or evidence of therapeutic relevance. Published research and druggable target databases instead reference PPP5C as a protein-coding gene encoding Serine/threonine-protein phosphatase 5, implicated in cell signaling, cancer, and other cellular pathways. There is no evidence that PPP5C-AS1 itself is a validated target or that it plays a well-defined biological or disease-specific role. If the query is intended to refer to the well-studied protein phosphatase PPP5C, abundant information is available for that entity, but not for PPP5C-AS1. The lack of aliases, molecular classification, function, and disease link for PPP5C-AS1 indicates missing or incorrect information regarding its status as a canonical target.
None described for PPP5C-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PPP5C antisense RNA 1 (PPP5C-AS1).